Paper40642005
Editorial: Application of PKPD modeling in drug discovery and development.
Ren HC and 3 others. Front Pharmacol, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Editorial: Application of PKPD modeling in drug discovery and development. Papers, record 40642005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40642005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40078286 | High-performance PBPK model for predicting CYP3A4 induction-mediated drug interactions: a refined and validated approach. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40078286 | PubMed |
| 2 | 38477045 | In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell lines. | Clin Transl Sci | 2024 | https://conductscience.org/library/papers/38477045 | PubMed |
| 3 | 38738473 | Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development. | Xenobiotica | 2024 | https://conductscience.org/library/papers/38738473 | PubMed |
| 4 | 38049651 | PBPK/PD Modeling of Nifedipine for Precision Medicine in Pregnant Women: Enhancing Clinical Decision-Making for Optimal Drug Therapy. | Pharm Res | 2024 | https://conductscience.org/library/papers/38049651 | PubMed |
| 5 | 37746740 | Enhancing drug-drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4. | Expert Opin Drug Metab Toxicol | 2023 | https://conductscience.org/library/papers/37746740 | PubMed |
| 6 | 35694247 | Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35694247 | PubMed |
| 7 | 38375820 | Model-Based Virtual PK/PD Exploration and Machine Learning Approach to Define PK Drivers in Early Drug Discovery. | J Med Chem | 2024 | https://conductscience.org/library/papers/38375820 | PubMed |
| 8 | 34893925 | Predicting the Drug-Drug Interaction Mediated by CYP3A4 Inhibition: Method Development and Performance Evaluation. | AAPS J | 2021 | https://conductscience.org/library/papers/34893925 | PubMed |
| 9 | 30039459 | Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors. | Eur J Drug Metab Pharmacokinet | 2019 | https://conductscience.org/library/papers/30039459 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42086809 | AI and network biology for rational polypharmacology in signaling drug design: a review. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42086809 | PubMed |
| 42084805 | Advancing Wider Implementation of Multi-regional Clinical Trials in East Asia. | Ther Innov Regul Sci | 2026 | https://conductscience.org/library/papers/42084805 | PubMed |
| 41901196 | Physiology-Based Pharmacokinetic Modeling of Ropivacaine After External Oblique Intercostal Plane Block in Open Liver Surgery Patients. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901196 | PubMed |
| 41321494 | A model to simulate human cardio-respiratory responses to ketamine analgesia. | Front Physiol | 2025 | https://conductscience.org/library/papers/41321494 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FAP | 2191 | PubTator's text mining | https://conductscience.org/library/genes/2191 | NCBI Gene |
| FCGRT | 2217 | PubTator's text mining | https://conductscience.org/library/genes/2217 | NCBI Gene |
| MSH3 | 4437 | PubTator's text mining | https://conductscience.org/library/genes/4437 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40642005
GET https://conductscience.org/api/papers/v1/40642005/authors